EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

A new T‐antigen negative HEK293 cell line with improved AAV productivity

Coralie Croissant, Joshua Armitano, Bertrand Lazuech, Danijel Švec, Cyril Pugin, Anaïs Guesdon, Louise Bryan, Antonio Castro, Léa Neuhaus, Giulia Fonti, Jacopo Martinis, Maria J Wurm and 2 more

Biotechnology and Bioengineering · 2023

DOI: 10.1002/bit.28414 ↗

At a glance

Journal article in Biotechnology and Bioengineering, 2023. Written by Coralie Croissant and 13 co-authors. Institution: ExcellGene SA, Monthey, Switzerland. Major MEDLINE topics: Antigens, Viral, Tumor, Genetic Vectors. Cited 5 times so far (Crossref); 24 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Viral vectors for gene therapy, such as recombinant adeno‐associated viruses, are produced in human embryonic kidney (HEK) 293 cells. However, the presence of the SV40 T‐antigen‐encoding CDS SV40GP6 and SV40GP7 in the HEK293T genome raises safety issues when these cells are used in manufacturing for clinical purposes. We developed a new T‐antigen‐negative HEK cell line from ExcellGene's proprietary HEKExpress,® using the CRISPR‐Cas9 strategy. We obtained a high number of clonally‐derived cell populations and all of them were demonstrated T‐antigen negative. Stability study and AAV production evaluation showed that the deletion of the T‐antigen‐encoding locus did not impact neither cell growth nor viability nor productivity. The resulting CMC‐compliant cell line, named HEKzeroT,® is able to produce high AAV titers, from small to large scale.

Subjects

MeSH terms (MEDLINE)

Antigens, Viral, TumorGenetic VectorsHumansHEK293 CellsDependovirus

Author keywords

AAVHEK293T-antigengene therapymanufacturing

Substances

Antigens, Viral, Tumor

Authors and institutions

  • ExcellGene SA, Monthey, Switzerland.

ORCID profiles: Paco Pino

Cite

APA

Croissant, C., Armitano, J., Lazuech, B., Švec, D., Pugin, C., Guesdon, A., Bryan, L., Castro, A., Neuhaus, L., Fonti, G., Martinis, J., Wurm, M. J., Wurm, F. M., & Pino, P. (2023). A new T‐antigen negative HEK293 cell line with improved AAV productivity. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28414

Vancouver

Croissant C, Armitano J, Lazuech B, Švec D, Pugin C, Guesdon A, et al. A new T‐antigen negative HEK293 cell line with improved AAV productivity. Biotechnology and Bioengineering. 2023. doi:10.1002/bit.28414

BibTeX
@article{Croissant2023,
  author = {Croissant, Coralie and Armitano, Joshua and Lazuech, Bertrand and Švec, Danijel and Pugin, Cyril and Guesdon, Anaïs and Bryan, Louise and Castro, Antonio and Neuhaus, Léa and Fonti, Giulia and Martinis, Jacopo and Wurm, Maria J and Wurm, Florian M and Pino, Paco},
  title = {A new T‐antigen negative HEK293 cell line with improved AAV productivity},
  journal = {Biotechnology and Bioengineering},
  year = {2023},
  doi = {10.1002/bit.28414}
}
Start for free →